IS<i>1</i>-related large-scale deletion of chromosomal regions harbouring the oxygen-insensitive nitroreductase gene <i>nfsB</i> causes nitrofurantoin heteroresistance in <i>Escherichia coli</i>.

Publication Year: 2023

DOI:
10.1099/mgen.0.001102

PMCID:
PMC10569738

PMID:
37672334

Journal Information

Full Title: Microb Genom

Abbreviation: Microb Genom

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Microbiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
5/6
83.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"further frequencies of resistant subpopulations from nitrofurantoin-heteroresistant isolates may challenge conventional nitrofurantoin susceptibility testing in clinical settings comparative genomics escherichia coli insertion sequences nitrofurantoin heteroresistance population analysis profiling whole-genome sequencing structural variation is1 elements resistance mechanism hybrid genome assembly openaccessembargo 0 whole-genome sequencing reads and genome assemblies generated in this study have been deposited under bioproject prjeb58678 in the european nucleotide archive (ena).; previously generated illumina whole-genome sequencing reads of progenitor isolates ec0026b and ec0880b are available under ena accessions err3142418 and err3142524 respectively.; illumina whole-genome sequencing (wgs) reads of ec0026b and ec0880b have been generated previously [ ] and are available under accessions err3142418 and err3142524 respectively in the ena."

Evidence found in paper:

"scripts used for aforementioned steps are available at github com/wanyuac/assembly_toolkit."

Evidence found in paper:

"Conflicts of interest The authors declare that there are no conflicts of interest."

Evidence found in paper:

"Funding information This study was funded by the UK Health Security Agency under United Kingdom National Action Plan on Antimicrobial Resistance (2019–2024)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025